Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-25 @ 9:26 PM
NCT ID: NCT01184456
Description: PI has left AIDS Healthcare Foundation, all efforts to locate the data have been exhausted and no data is available.
Frequency Threshold: 0
Time Frame: PI has left AIDS Healthcare Foundation, all efforts to locate the data have been exhausted and no data is available.
Study: NCT01184456
Study Brief: A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
GanedenBC30, GBI-30, PTA-6086 GanedenBC30, GBI-30, PTA-6086: 1 capsule per day containing 2 billion CFU of GanedenBC30, GBI-30, PTA-6086 for 90 days. None None 0 0 0 0 View
Placebo Placebo: 1 capsule per day for 90 days. None None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):